FDA Inspection
LifeShare Blood CentersLifeShare Blood Centers – FDA Inspection, Jun 28, 2018
Record Details
This FDA Inspection record concerns LifeShare Blood Centers, with an inspection on June 28, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b2ca5fc9-0812-4c6e-8fae-5688b4f7d597
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059869
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of LifeShare Blood Centers
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 16, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 1, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Centers
- FDA Inspection 1222369 - 2023-10-26
- FDA Inspection 1106632 - 2019-09-24
- FDA Inspection 960573 - 2016-02-16
- FDA Inspection 816581 - 2013-02-01
- FDA Inspection 683132 - 2010-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.